Novel therapeutic approach for spinal cord injury

Antibodies which block the action of the growth inhibitor Nogo-A allowed the regrowth of injured fibers and the formation of new connections in animal models. The NovaGo antibody NG004 is an optimized regeneration-promoting drug which currently enters clinical trials.